![Page 1: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/1.jpg)
Welcome to ASTRO 2017
![Page 2: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/2.jpg)
Important information
This presentation includes forward-looking statements including, but not limited to, statements relating to
operational and financial performance, market conditions, and other similar matters. These forward-looking
statements are based on current expectations about future events. Although the expectations described in
these statements are assumed to be reasonable, there is no guarantee that such forward-looking
statements will materialize or are accurate. Since these statements involve assumptions and estimates
that are subject to risks and uncertainties, results could differ materially from those set out in the
statement. Certain of these risks and uncertainties are described further in the Annual Report in section
“Risks and uncertainties”. Elekta undertakes no obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise, except as required by law
or stock exchange regulations.
This presentation is intended for investors and analysts only. Some products are still in research and/or not
cleared/approved in all markets. Cancer statistics are given to show the potential market in the respective
area and does not mean that Elekta currently has products to treat these indications.
2 | Focus where it matters
![Page 3: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/3.jpg)
Richard Hausmann, PhDPresident and CEO Elekta AB
![Page 4: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/4.jpg)
4 | Focus where it matters
The world today
![Page 5: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/5.jpg)
5 | Focus where it matters
What is the difference between those two cars?… and what does this have to do with radiotherapy?
![Page 6: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/6.jpg)
6 | Focus where it matters
It’s the connectivity – the sensors –
and the intelligence built in the
“system”
![Page 7: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/7.jpg)
7 | Focus where it matters
Global trends and the challenge to remain relevant
Info & analytics key
to the future
Interoperability needs are
increasing
Global connectivity for
networks data sharing
Expect a merging of
[medical] disciplines
… and more!
![Page 8: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/8.jpg)
8 | Focus where it matters
New technologies changing the future of medicineFrom paper maps [Films] to digital maps [PACS] to Google maps [Health Cloud]
![Page 9: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/9.jpg)
9 | Focus where it matters
Elekta today
![Page 10: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/10.jpg)
10 | Focus where it matters
New version
SOFTWARE
SOLUTIONS
TREATMENT
SOLUTIONS
SE
RV
ICE
& S
UP
PO
RT
PR
OF
ES
SIO
NA
L
SE
RV
ICE
S
Solutions to provide efficient and precise treatments
(from Imaging, QA to delivery) in cancer care and
neurological diseases
Solutions to manage the oncology treatment
pathway and related data for the department/network,
irrespective of choice of treatment & vendor
![Page 11: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/11.jpg)
11 | Focus where it matters
New version
SOFTWARE
SOLUTIONS
TREATMENT
SOLUTIONS
MOSAIQ
Oncology
Information System
MOSAIQ
Oncology
Analytics
Image & Plan
Review
METRIQ/LGK
Cancer Registries
SE
RV
ICE
& S
UP
PO
RT
Versa HD Flexitron Leksell GammaKnife Icon
Brachy NeuroLinac
Monaco
Adaptive planning
incl. PT
Unity*
PR
OF
ES
SIO
NA
L
SE
RV
ICE
S
Plan of care
Oncology Informatics
Proton
Treatment pathway Management
*Research, not for sale in all regions
Vendor agnostic
AI enabled
Pathway centric
Precise & efficient
Imaging centric
Adaptive workflows
MR Linac
![Page 12: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/12.jpg)
We as Elekta are
accelerating the
technology transition:
• OIS with MOA
• SRS with HDdRS
• Scan-plan-treat with
our Unity*
*Elekta Unity is not available for sale or distribution in the USA or Canada and has not
been submitted for 510(k) premarket clearance
![Page 13: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/13.jpg)
13 | Focus where it matters.
FILM clip
![Page 14: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/14.jpg)
Bladder
Rectal tumor
Esophagus
MR-linac
(future)
Elekta UnityBrings together the capability of high-field diagnostic MR imaging, the highest standard of precision radiation therapy delivery and sophisticated adaptive workflow software for the first time.
Cone beam IGRT
(today)
![Page 15: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/15.jpg)
15 | Focus where it matters.
• 16 systems as of today; 7 founding consortium sites and 9 additional hospitals
• 5 in North America (R&D sites)
• Interesting technology for many potential clients
• Entrance to key university and teaching sites
Elekta Unity* – will revolutionize radiation therapy
*Elekta Unity is not available for sale or distribution in the USA or Canada and has not
been submitted for 510(k) premarket clearance
![Page 16: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/16.jpg)
16 | Focus where it matters.
Commercialization on track
ESTROpresentation
First patient treated
ASTROSeptember
2017
Target: CE-mark 2017
Target: 510k submission
2017
RSNA2017
![Page 17: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/17.jpg)
First patient study
completed at
at UMC
”Analysis of the first clinically
derived data shows that visibility of
the treatment target and
simultaneous radiation beam
accuracy is excellent and beyond
expectations”
![Page 18: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/18.jpg)
18 | Focus where it matters
First-in-man treatments on Elekta Unity*
Uncompromised
diagnostic imaging quality
Image anywhere, anytimeHigh Speed (>15 images/s)
High Resolution (<1mm3)
Full breadth of diagnostic
MR sequences
Demonstrated technical
accuracy and safety in
the clinical setting
Patients with bone metastases treated with palliative intention.
Results “Better than expected” Images courtesy of Utrecht MC.
*Elekta Unity is a Technology in Development.
![Page 19: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/19.jpg)
19 | Focus where it matters.
Long-term addressable market ~25% of current
installed linacs
TARGET
75 ordersuntil 2019
16 orders to date
Phase 1 Academic-driven phase
• High-profile clinics.
• ~300-400 units addressable market.
Phase 2 Broad scale - clinical adoption driven phase
• Larger mainstream profile, guidelines driven.
• ~3 000 units addressable market.
Momentum project - Further clinical research and data - Financial reimbursement/support
![Page 20: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/20.jpg)
20 | Focus where it matters
Elekta Unity* – Innovation Platform
*Elekta Unity is not available for sale or distribution in the USA or Canada and has not
been submitted for 510(k) premarket clearance
![Page 21: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/21.jpg)
21 | Focus where it matters.
Extraordinary potential with high field functional MR First evidence, quantitative imaging on Elekta Unity*
ADC
5 min
T2 map
2.5 min
From: Online quantitative imaging on the MR-Linac, ESTRO 36, F. Koetsveld et al, NKI
Online
Functional/Biologic
response
=
Potential for earlier
treatment adaptation
4 types* of functional
imaging proven robust
across Unity and
conventional MR
scanners
*T1 & T2 mapping, DCE & DWI
*Elekta Unity is not available for sale or distribution in the USA or Canada and has not
been submitted for 510(k) premarket clearance
![Page 22: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/22.jpg)
Elekta’s transformation
![Page 23: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/23.jpg)
Our transformation since
2015/16 - achievements
• Cost base reduction
• Focus in R&D and innovation
• Significant reduction of working capital and improved cash flow. Implementation of produce-to-installation process
• Integration of past acquisitions
• New organization, management and leadership development
![Page 24: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/24.jpg)
24 | Focus where it matters.
Visible results in improved cash flow and NWC
-6%-8%
-4%
0%
4%
8%
12%
Q3 Q4 Q1 Q2 Q3 Q4 Q1
Net working capital
as % of sales
79%
60%
126%
111%
145%150%
0%
20%
40%
60%
80%
100%
120%
140%
160%
12/13 13/14 14/15 15/16 16/17 R12
Improved cash conversion
(op cash flow / EBITDA)
400
800
1 200
1 600
2 000
11/12 12/13 13/14 14/15 15/16 16/17 Q1
Accrued income (SEK M)
![Page 25: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/25.jpg)
New management team
Richard Hausmann CEO
Gustaf Salford CFO
Ioannis Panagiotelis Chief Marketing and Sales Officer
Maurits Wolleswinkel Head of Portfolio and Chief Strategy Officer
Steven Wort Chief Operating Officer
John Lapré Chief Technology Officer
Peter Gaccione EVP North America
Anming Gong EVP Region China
Jonas Bolander General Counsel
Karin Svenske Nyberg EVP Human Resources
Elekta Conference, Brighton, May 2017
![Page 26: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/26.jpg)
26 | Focus where it matters.
Foundation in place
Organization
Company organized
in line with three key
processesGrowth
Cost
Strategic priorities
Updated brand
Values
We work as
one team
We do what
we say
We keep thinking
forward
![Page 27: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/27.jpg)
27 | Focus where it matters.
Our way forward has started
2016/17
• Year of change and building the foundation for profitable growth
• Produce-to-order and ship-to-installation completed
2018/19
2017/18
• Transformation delivers full effect
• Organization and management in place
• Culture of continuous improvements
• Elevate customer experience
• Elekta Unity hits the market
2018/19
• Elekta Unity – growth driver
• Significant efficiency improvements
• Further product innovations based on the Elekta Digital platform
![Page 28: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/28.jpg)
28 | Focus where it matters.
Targets for 2017/18
Growth
Reach
>20% EBITAmargin
Net workingcapital
<5%to net sales
![Page 29: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/29.jpg)
Welcome to ASTRO 2017!
Ioannis PanagiotelisChief Marketing and Sales Officer
![Page 30: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/30.jpg)
30 | Focus where it matters.
- Largest booth space ever at ASTRO, 780m2
- Elekta Unity – central role (research system)
- Unity pre-launch activities – evening event tonight 1,000 participants
- Elekta Users meeting >600 participants
- Complete portfolio showcased with common vision
Highlights at ASTRO 2017
![Page 31: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/31.jpg)
Elekta User Meeting >600 participants
Key Note Speaker - Guy Kawasaki
Adminstrator23%
Medical Dosimetrist
5%
Medical Physicist
23%
Nurse2%
Other 3%
Radiation Oncologist
20%
Radiation Therapist
19%
IT5%
RNA70%
RLA11%
REU6%
RAP3%
China10%
![Page 32: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/32.jpg)
32 | Focus where it matters
MR-linac reveal
![Page 33: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/33.jpg)
33 | Focus where it matters.
Elekta evening event - TONIGHTHilton San Diego Bayfront ~1 000 participants
![Page 34: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/34.jpg)
34 | Focus where it matters
Our portfolio
![Page 35: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/35.jpg)
35 | Focus where it matters.
![Page 36: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/36.jpg)
Leksell
Gamma
Knife®
Icon™
![Page 37: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/37.jpg)
37 | Focus where it matters
50 Leksell Gamma Knife Icon units in clinical use
37
25 16 9
Large cancer clinics adopting LGK Icon
Cleveland Clinic, Cleveland, OH, Emory St. Joseph’s, Atlanta, GA, Univ Texas South West, Dallas, TX, MD Anderson, Houston, TX, Mary Bird Perkins Cancer Center, Louisana, USA,
![Page 38: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/38.jpg)
Versa HD
![Page 39: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/39.jpg)
High definition dynamic
radiosurgery
Monaco + Agility + VMAT =
Fast delivery and low dose to surrounding healthy tissue
Dynamic jaws
can modulate
within leaves to
mimic 1mm
resolution
MLC’s can be
positioned in
1mm increments
![Page 40: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/40.jpg)
MOSAIQ®
![Page 41: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/41.jpg)
41 | Focus where it matters
Manuallydriven
Oncology Analytics
Film & paper charts
Electronic patient
charting
Workflow customization
Workflow automation and
quality control tools
2003 20172005 2012 2015
MOSAIQ contains all the tools to support value
based medicine today
![Page 42: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/42.jpg)
42 | Focus where it matters.
![Page 43: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/43.jpg)
Empower every action
with MOA
Enhance Patient Care
Optimize Operations
Improve Cost Savings
![Page 44: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/44.jpg)
EXTENSIVE MARKETING
PROGRAM
ASTRO 2017
LEADING PRODUCT
OFFERING
INNOVATION LEADER
WITH MR LINAC
![Page 45: Welcome to ASTRO 2017 - Elekta AB€¦ · Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future](https://reader034.vdocuments.mx/reader034/viewer/2022050415/5f8ba26bd94e0065964842aa/html5/thumbnails/45.jpg)